Literature DB >> 7728394

Heterogeneity of disease phenotype in monozygotic twins concordant for rheumatoid arthritis.

A J MacGregor1, S Bamber, D Carthy, J Vencovsky, R A Mageed, W E Ollier, A J Silman.   

Abstract

The objective of the study was to investigate the genetic contribution to the clinical expression of rheumatoid arthritis (RA) by comparison of disease features in RA-concordant monozygotic (MZ) twin pairs. Fourteen RA-concordant MZ twin pairs recruited from a nation-wide study were examined to determine the degree of similarity in: (a) age of disease onset; (b) pattern of joint involvement; (c) pattern of extra-articular disease; (d) toxic reactions to drugs; (e) disease course; and (f) serology for rheumatoid factor (RF) and antinuclear antibody. There was considerable within-pair diversity in the variables studied. Some similarity within twin pairs was observed for the ages at disease onset (R = 0.63), presence of erosive changes (kappa = 0.61) and the presence of IgM RF (R = 0.87). No important similarity was seen, however, in the pattern of joint involvement, the occurrence of extra-articular disease, adverse drugs reactions, clinical disease course and reported disability level. There is heterogeneity in the genetic contribution to the clinical expression of RA. The overall lack of similarity for the majority of clinical variables indicates the importance of non-genetic factors on the expression of disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728394     DOI: 10.1093/rheumatology/34.3.215

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  8 in total

1.  Using twin studies to label disease as genetic or environmental is inappropriate.

Authors:  Alex J MacGregor; Jerry Lanchbury; Alan S Rigby; Jaakko Kaprio; Harold Snieder
Journal:  BMJ       Date:  2002-05-04

Review 2.  Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis.

Authors:  P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 3.  A Roadmap for Investigating Preclinical Autoimmunity Using Patient-Oriented and Epidemiologic Study Designs: Example of Rheumatoid Arthritis.

Authors:  Emily N Kowalski; Grace Qian; Kathleen M M Vanni; Jeffrey A Sparks
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

4.  The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients.

Authors:  Babak Yazdani-Biuki; Kerstin Brickmann; Klaus Wohlfahrt; Thomas Mueller; Winfried März; Wilfried Renner; Manuela Gutjahr; Uwe Langsenlehner; Peter Krippl; Thomas C Wascher; Bernhard Paulweber; Winfried Graninger; Hans-Peter Brezinschek
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

5.  Differentially Methylated DNA Regions in Monozygotic Twin Pairs Discordant for Rheumatoid Arthritis: An Epigenome-Wide Study.

Authors:  Anders J Svendsen; Kristina Gervin; Robert Lyle; Lene Christiansen; Kirsten Kyvik; Peter Junker; Christian Nielsen; Gunnar Houen; Qihua Tan
Journal:  Front Immunol       Date:  2016-11-17       Impact factor: 7.561

Review 6.  From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Shue-Fen Luo; Jenn-Haung Lai
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

7.  Management of rheumatoid arthritis (Aamavata) using symbiohealth healthcare system.

Authors:  Gopal K Basisht; Ram Harsh Singh; Harimohan Chandola
Journal:  Ayu       Date:  2012-10

8.  Large-scale linkage analysis of 1302 affected relative pairs with rheumatoid arthritis.

Authors:  Marian L Hamshere; Ricardo Segurado; Valentina Moskvina; Ivan Nikolov; Beate Glaser; Peter A Holmans
Journal:  BMC Proc       Date:  2007-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.